Indication
Enterococcal endocarditis
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis*. Read more about Enterococcal endocarditis
78 drugs 45 manufacturers
Drugs that treat it
Common Enterococcal endocarditis therapies.
TYZAVAN (vancomycin HCl in water for injection (NADA,lysine))
AMPICILLIN SODIUM
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEnterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis*.
Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness.
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization.
- nih.gov
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis* Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness
- clinicaltrials.eu
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis* Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- nih.gov
Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness
- nih.gov
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- nih.gov
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- idsociety.org
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
Personalize your experience
Follow Enterococcal endocarditis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.